Short elimination half–life (8–10 min) of esmolol (beta–adrenergic blocker) is due to:
Esmolol is a beta-adrenergic blocker, specifically a beta-1 blocker. I remember that beta-blockers can have different half-lives. Esmolol is known for its very short half-life, which makes it useful in situations needing rapid onset and offset, like during surgery or acute hypertension.
Short half-life usually relates to how the drug is metabolized and excreted. Esmolol is a very short-acting drug, so it must be metabolized quickly. Beta blockers like metoprolol or propranolol have longer half-lives. The key here is the mechanism of elimination. Esmolol is primarily metabolized by esterases in the blood and liver. Ester hydrolysis is a rapid process because esterases are abundant and efficient at breaking down ester bonds. This leads to quick inactivation of the drug, hence the short half-life.
So the correct answer would be that esmolol's short half-life is due to rapid metabolism by plasma esterases. Let me check the common distractors. Options might include renal excretion, hepatic metabolism via CYP enzymes, or protein binding. But esmolol isn't significantly bound to plasma proteins, so protein binding isn't a factor. Renal excretion would require the drug to be filtered by the kidneys, but since it's metabolized before that, that's not the case. CYP enzymes usually take longer for metabolism, so that's less likely. Therefore, the correct answer is the esterase metabolism.
**Core Concept**
Esmolol’s short half-life is due to its unique pharmacokinetic profile. As an ultrashort-acting beta-blocker, it is rapidly metabolized by nonspecific plasma esterases, bypassing hepatic metabolism. This makes its elimination highly predictable and independent of liver or kidney function.
**Why the Correct Answer is Right**
Esmolol contains an ester functional group that is hydrolyzed by plasma and hepatic esterases. This enzymatic breakdown occurs rapidly (within minutes), inactivating the drug before it can undergo hepatic metabolism or renal excretion. The absence of tissue storage and lack of active transport mechanisms further accelerate its clearance.
**Why Each Wrong Option is Incorrect**
**Option A:** Renal excretion is incorrect because esmolol is metabolized before significant renal clearance occurs.
**Option B:** Hepatic metabolism via CYP enzymes is incorrect; esmolol is primarily inactivated by esterases, not cytochrome P450 pathways.
**Option C:** High protein binding is incorrect; esmolol has low plasma protein binding (~6–10%), allowing rapid hydrolysis of free drug.
**Clinical Pearl / High-Yield Fact**
Esmolol is the beta-blocker of choice for acute situations (e.g., perioperative hypertension, atrial fibrillation) due to its rapid onset and offset. Remember: **ester = esterase = fast metabolism**. Contrast with metoprolol (hepatically metabolized, longer half-life).
**Correct Answer: D. Rapid metabolism